Home›Companies›MedCrypt

MedCrypt Inc.

Updated Oct 27, 2026·Latest SEC filing Feb 19, 2025·Suggest an edit

About MedCrypt

MedCrypt is a private company based in Solana Beach, California. It has reported $39,688,274 raised in four offerings on Form D since August 2016. Its chief executive is Michael Kijewski.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Feb 4, 2025Feb 19, 2025$8,301,480of $8.6M target18$461KDebtRule 506(b)Form D ↗
Oct 4, 2022Nov 8, 2022$25,191,432of $25.5M target31$812KEquityRule 506(b)Form D ↗
May 2, 2019May 8, 2019$5,455,372fully sold17$320KEquityRule 506(b)Form D ↗
Aug 1, 2016Aug 9, 2016$739,990of $1.2M target13$56,922Debt, Securities on exercise, Debit convertible into stock upon certain events.Rule 506(b)Form D ↗
Total, four offerings$39,688,274

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on MedCrypt's Form D filed Feb 19, 2025.

VM
Vidya Murthy
Executive officer
AC
GK
TM
Tamir Meiri
Director
MK
Michael Kijewski
CEO and director
MP
Mike Pellini
Director

Earlier filings also listed Timothy Young (director, last listed Nov 2022), Michael McNeil (director, last listed Nov 2022), Eric Pancoast (director, last listed Nov 2022), Brett Falik (executive officer, last listed Nov 2022), Brett Falk (executive officer and director, last listed May 2019) and Brett Hemenway Falk (executive officer and director, last listed Aug 2016).

Sources

  1. SECMedCrypt Inc. filing history